‘Ozempic face' may be driving a cosmetic surgery boom
'Although they felt much better losing weight, in some ways they felt they looked older,' he said via a voice note. 'And this was due to the loss of volume in their face.'
Frank started using the term 'Ozempic face' — a label he believes he coined — to describe the phenomenon. It has since become a social media byword for the sagging skin and hollowed-out appearance that can accompany the use of GLP-1 medications like semaglutide (the active ingredient in branded drugs such as Ozempic and Wegovy).
'Usually, with people from their mid-40s and above, once you start losing 10-plus pounds, you can get this kind of deflated look,' said Frank, who is the founder of aesthetic health care brand PFRANKMD and the author of 'The Pro-Aging Playbook.' 'Certainly, people losing 20 or 30-plus pounds are going to have this problem.'
Semaglutide works by stimulating the pancreas to trigger insulin production, curbing users' appetite and contributing to feelings of fullness. Although the US Food and Drug Administration approved Ozempic to treat type 2 diabetes, doctors now commonly prescribe it off-label for weight management. About 1 in 8 adults in the US has used a GLP-1 drug, and of those, around 2 in 5 did so solely to lose weight, according to health policy non-profit KFF in 2024.
Today, more than 20% of Frank's patients are using GLP-1s as part of what he called their 'longevity regimen.' The treatments sought after their weight loss include injectable dermal fillers to help restore facial volume, facelifts and fat transfers.
'You can only refill a deflated balloon so much, and often surgical intervention is necessary,' he said. But for many patients, he added, 'just upping the dosage of their volume replacement is more than enough.
'Someone who may have used one syringe of filler in the past is now using two or three.'
'It looked like I had melted'
The American Society of Plastic Surgeons (ASPS), which publishes an annual report on surgery trends, recently found that 2 in 5 of its members' GLP-1 patients were considering undergoing cosmetic surgery — and 1 in 5 already had.
Among the patients opting for a facelift was Kimberly Bongiorno, a local government land use administrator from Mount Arlington, New Jersey. Having lost weight after gastric sleeve surgery in 2019, she regained 40 pounds during the Covid-19 pandemic and was prescribed Wegovy last year. Despite describing the drug's impact as 'almost a miracle' — taking her weight from 170 to 125 pounds — the 55-year-old faced new concerns over her appearance.
'Everything just kind of hung and was very loose,' she said over Zoom, recalling seeing her face in a photo shared by a friend. 'I no longer felt like I had cheeks, and I had a lot of loose skin under my neck.
'It looked like I had melted. It was horrifying,' she added. 'It was so disheartening to see how my face looked and how it had changed, I thought I looked a lot older than I am.'
After consulting plastic surgeon Dr. Anthony Berlet at his New Jersey office, Bongiorno underwent a deep plane facelift that lifted her skin and repositioned some of the deeper muscles and connective tissues. She also opted for a neck lift that refined and smoothed her neck contours while addressing excess skin left by her weight loss.
'Before I did this, I probably looked closer to 60, or maybe even older. And now I have people who I've recently met think I am in my 40s,' Bongiorno said, adding: 'People I haven't seen in a while say, 'You look so healthy and happy.' And that's nice to hear, because for a while, I didn't look healthy and certainly wasn't happy.'
The number of facelifts performed in the US jumped 8% between 2022 and 2023, according to ASPS data. The use of hyaluronic acid fillers has meanwhile doubled from 2.6 million Americans in 2017 — the year Ozempic was first cleared for diabetes — to over 5.2 million in 2023.
The organization could not attribute these upticks exclusively to GLP-1 use, but its former president, Dr. Steven Williams, said the medications have had 'a global effect on aesthetic surgery.'
'Now we have a brand-new tool that actually has efficacy for so many patients,' said Williams, a board-certified plastic surgeon and founder of California's Tri Valley Plastic Surgery, over Zoom. He noted that GLP-1s come 'without substantial drawbacks' when compared with invasive procedures like gastric bypass surgery.
'We can now have an honest conversation with patients about a nonsurgical tool that's effective in weight loss,' he added. 'And as part of that conversation, there's an obligation to say, 'Look, this is really going to work, so you have to be prepared for what looking 20 or 50 pounds slimmer is going to be.''
The term 'Ozempic face' may speak to our times, but its symptoms — caused by a decrease in the subcutaneous fat that makes our faces plump — are nothing new. Cosmetic surgeons have long been treating the side effects of significant weight loss. In fact, one popular brand of dermal filler, Sculptra, was originally developed in the 1990s for HIV patients.
As an adult, 'your body actually doesn't make more fat cells,' Williams said. 'As we lose or gain weight, those fat cells aren't multiplying or decreasing; they're getting bigger or smaller. And so as we lose weight, those fat cells now have decreased volume, and there's just less fullness.'
Preventive measures
Age can determine how patients' faces react to weight loss. People in their 20s and 30s, for instance, are far less likely to experience the appearance of aging due to GLP-1 use, Frank said.
'Because they have good skin elasticity, the skin rebounds much better,' he said.
Patients aged 20 to 39 accounted for 14% of hyaluronic acid filler use in the US and just 2% of facelift procedures last year, according to the ASPS. But both figures are on the rise.
Gabriela Vasquez, 29, is among the younger patients using GLP-1 to undergo cosmetic procedures after rapid weight loss. An employee of one of Williams' Tri Valley Plastic Surgery clinics, she has dropped around 50 pounds since starting Ozempic in November.
Although Vasquez is still working toward her target weight, she sought preventative Botox injections (more visible lines and wrinkles are, along with thinning lips, among the other side effects of GLP-1 use). She has also recently undergone microneedling, a procedure used to stimulate collagen production.
'One of my concerns was my jowls, because I felt I saw them when I was a little heavier,' she said over Zoom from the Bay Area. 'I think the microneedling definitely helped.
'I never had a jaw line,' she added. 'And a couple weeks ago, someone took a picture of me, and I had one, and I was like, 'Well, that's new.''
Vasquez did not rule out further cosmetic procedures as she continues losing weight — and not only to her face and neck. 'I'm seeing little things in my body that I'm like, 'Whoa, that would be nice to take care of,'' she said, referencing the appearance of excess skin under her arms. 'I could see myself — later down the line, once I get to my goal weight — doing something to kind of tighten everything up.'
Frank, the cosmetic dermatologist, noted that 'Ozempic face' may be accompanied by a phenomenon he dubbed 'Ozempic body,' adding: 'One of the other major side effects of weight loss, particularly when it's done at a rate of more than one to two pounds a week, is muscle loss. And we see this all over the body.'
The ASPS similarly notes the emerging term 'Ozempic makeover,' a suite of procedures that might also include tummy tucks, breast lifts and arm, thigh and buttock lifts.
For instance, Bongiorno, the New Jersey facelift patient, has also undergone several other procedures with Dr. Berlet, including arm and thigh lifts, to address her excess skin. She estimates that after her upcoming breast lift, fat grafting and lower eyelid surgery, she will have spent about $80,000 on cosmetic procedures.
'Skin is heavy and uncomfortable,' she said. 'This wasn't something I did to go out there and be a supermodel. It was just to be comfortable, so I could get clothes on and not feel like I was dragging around all this extra weight.'
Ongoing questions
The long-term effect of GLP-1 medications on cosmetic medicine is yet to be fully understood. The assumption they might reduce demand for liposuction, for instance, has not come to bear: It remains the most common cosmetic surgical procedure in the US, growing in popularity by 1% last year, per ASPS data.
What also remains to be seen is the effect that 'Ozempic rebound' — when patients regain weight after stopping the drugs — has on people who sought cosmetic procedures.
A recent peer-reviewed study found that most people using the drugs for weight loss quit within a year. Data presented at this year's European Congress on Obesity meanwhile suggested that patients typically returned to their original weight within 10 months of stopping use, with University of Oxford researchers calling the findings a 'cautionary note' about using medication 'without a more comprehensive approach' to weight loss.
For Williams, this further demonstrates why he and his plastic surgeon colleagues must take responsibility for their patients' 'entire journey,' not just their cosmetic procedures.
'We don't want these patients to be on these medications for a lifetime. We want it to be a temporary bridge to a healthier lifestyle,' he said, adding: 'It's our obligation to work harder with those patients, to talk about lifestyle changes, to get them plugged in to dietitians and to make sure that they're building muscle and exercising.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
2 hours ago
- New York Post
I went blind after doing cartwheels — here's what I learned after losing my vision
A woman who lost her ability to see after a joyful romp on the beach is opening up about the frightening ordeal. Deborah Cobb was 19 years old when she broke out in a series of cartwheels — only to come up without her vision. Now 42, Cobb has said that she has the ocular health of an 80-year-old and anticipates she will soon return to blindness due to early-onset macular degeneration. Advertisement 4 Seemingly harmless horseplay caused temporary blindness and chronic illness for one 19-year-old woman. Mikhail Ulyannikov – In a new interview with Newsweek, Cobb said she was with her friends when she decided to challenge herself to do as many cartwheels in a row as she could 'just for fun.' 'I started doing them and got to 13 and fell over super dizzy. My eyes were kind of spinning, so it took a moment to realize that my eyes weren't focusing,' she recalled. Advertisement 'Looking at her face, it was a giant orange blur,' Cobb continued, referring to a friend who witnessed the shocking moments. 'My eyes wouldn't fully focus. There was no pain, and my peripheral vision was fine, but everything I looked directly at was blocked by an orange blur.' Cobb's harrowing story went viral in a recent post on Instagram, where she detailed the mysterious medical phenomenon that doctors first thought was a sign of leukemia and even AIDS. 'I had neither. Just weak blood vessels in my eyes that is apparently a genetic trait as I later learned,' she wrote of her condition, called macular degeneration. 4 Deborah Cobb, now 42, shared details of her macular degeneration diagnosis on Instagram. deborahcobb_ihp/Instagram Advertisement Cobb explained in the viral video post that her gymnastic stunts had caused internal hemorrhages in a part of her eye called the macula, an area at the center of the retina that is responsible for sharp, focused vision. Macular degeneration is the leading cause of vision loss, affecting more than 200,000 Americans every year, usually brought on by old age and other factors, including genetics and cardiovascular disease. The condition causes blurred and distorted vision, dark spots changes in color perception. She was deemed 'legally blind' for three months after the initial incident, and did not regain full vision for another three months thereafter. 4 Macular degeneration, usually only seen in the elderly, affects the eye's ability to bring sight into sharp focus. mihai – Advertisement Cobb's life came to a halt during that time. As a result of the injury, she was forced to quit massage school. She couldn't drive, watch TV or even look at herself in the mirror. Though she was eventually able to return to school and later earned her license in massage therapy, she still lives in fear of losing her vision again. 'I can't do anything upside down or anything that causes too much blood to rush to my head. It happened once from doing push-ups, so I have to limit myself physically,' Cobb wrote. 4 Due to her eye condition, Cobb can no longer engage in physically exhaustive activities without risk of losing her vision again. deborahcobb_ihp/Instagram The experience inspired Cobb to dedicate her career to integrative medicine, and she now works with clients who suffer from anxiety and nervous system dysregulation. Cobb has also said that losing her vision gave her a positive new outlook on life, saying she's so thankful for the lessons in empathy and 'to not take the simple things for granted.' 'I could live in fear because of it, or I could be filled with gratitude because of it,' Cobb concluded in the thoughtful post. 'I choose gratitude, because who wants to live in fear?!'
Bloomberg
5 hours ago
- Bloomberg
Healthy Living Helps the Aging Brain
A new study published in the Journal of the American Medical Association makes a compelling case that a healthy lifestyle does an aging brain good. That might sound obvious. Eat well, exercise, challenge yourself mentally, have an active social life and you'll be better off for it. Yet researchers are just starting to offer concrete data to support the theory that making conscientious lifestyle changes can lower the risk of dementia, which is estimated to affect some 6 million Americans.
San Francisco Chronicle
6 hours ago
- San Francisco Chronicle
In the age of Ozempic, is there still a role for weight-loss surgery?
As weight-loss medications like Ozempic exploded across the U.S. over the past four years, bariatric surgeons faced a bit of an existential crisis: Were their jobs about to become obsolete? For the first time, health care providers have a combination of highly effective therapies to offer patients with obesity, a condition that has long been one of the most difficult to treat. The outlook is especially exciting for patients who are severely overweight — including those who are considered too heavy for surgery. Indeed, there may exist a future where drugs and other interventions prevent people from ever becoming obese and needing weight-loss surgery. But that future is far off, say surgeons and other weight-loss experts. In fact, even as millions of Americans are now taking drugs that dramatically improve weight loss, surgeons say their tool may be more powerful than ever. 'A massive amount of people have tried these medications, so the question becomes: 'How well do they work and is there a role for bariatric surgery in the era of these drugs?'' said Dr. Jonathan Carter, a UCSF surgeon who specializes in minimally invasive procedures. Bariatric surgery has for decades been the most effective and durable weight-loss tool available. The specific procedures vary, but the most common operation now is the gastric sleeve surgery, in which a large portion of the stomach is removed. Roughly a quarter of a million Americans undergo a bariatric procedure each year. The surgeries are highly effective for weight loss — patients can lose about a third of their body weight within two years, and they generally keep off most of those pounds long-term. The side effects with the sleeve procedure are minimal and may include gas, bloating and nutritional deficiencies that can be alleviated with diet. Meanwhile, more than 1 in 10 Americans have now taken the newest weight-loss medications. On these drugs, patients can lose about 15% of their weight, but they must remain on the drugs for life — those who stop gain all of the weight back. Side effects are similar to the surgery. The drugs and the surgery work somewhat similarly by essentially quashing people's hunger and cravings. And though the surgery is more expensive at the outset — about $12,000 to $15,000 — it's cheaper in the long-term compared to drugs that cost about $1,000 a month. Both treatments are often, but not always, covered by insurance. With the surgery, 'You take someone who is 100 pounds overweight and their knees hurt and they have sleep apnea,' said Carter, 'and you do a one-hour intervention and a year later they've lost 100 pounds and their knees don't hurt and the sleep apnea is gone. It's like a butterfly coming out of a cocoon.' But bariatric surgery has never been a popular weight-loss option for those who need it most. Of all Americans who are eligible for surgery, only about 1% undergo the procedure. Surgeons and weight-loss experts say that's largely been due to misconceptions about the procedure and stigma around obesity. 'If you've been treating patients with obesity for decades, you always felt like, 'Yes, I have a great treatment, I can do these surgeries and do them safely, I believe in them whole-heartedly,'' said Dr. Dan Azagury, a Stanford University bariatric surgeon. 'But you were still limited in your capacity to treat patients.' Azagury took over Stanford's Lifestyle and Weight Management Center in February 2020, about a year before Ozempic, the first blockbuster weight-loss drug, blew up. Over the next 18 months, the number of patients on weight-loss medications jumped from 50 to 2,000. He said friends would often ask him if he would be out of a job soon. The drugs, though, have in some ways validated the surgical interventions, Azagury said. Weight loss has notoriously been a fraught topic in doctors offices, with patients feeling judged and doctors feeling frustrated by their lack of treatment options. 'A lot of times doctors would just say that you should eat less,' Azagury said. 'And I think patients intrinsically didn't see obesity as a medical condition,' he said. The success of recent weight-loss drugs, though, has made that conversation more palatable both to patients and providers, Azagury said. And he believes that is making some patients more amenable to a surgical option. There are, broadly, now three buckets for treating weight loss: diet and exercise, medication and surgery. The first option is likely best for people who don't have a lot of weight to lose and who are not facing any immediate complications related to their weight. They can manage their own treatment, or get a referral to a community or private weight-loss program. From there, patients with more serious obesity can decide if medication or surgery — or both — is the best option for them. Some people may be resistant to the idea of any surgical procedure and opt for medication. Others may decide that they would rather not deal with weekly injections for the rest of their life and prefer a one-time operation. Many patients, though, will end up with multiple interventions over their lifetime. They may start with medication and eventually decide they want a more permanent solution. Or they may get bariatric surgery and a few years later decide to start a medication if their weight is creeping back up. Mandy Hinz, 47, fought with her weight all her life, and it's only in the past two years that she finally felt like she had options. She had inquired about bariatric surgery about 20 years ago but was told she would need to lose 100 pounds before doctors would consider it safe. After that, she was up and down, peaking at about 415 pounds on her 5-foot, 3-inch frame. She started Ozempic in early 2023, and though the drug made her feel 'super sick,' she stuck with it and lost about 30 pounds. Around that time, Hinz, a Sacramento resident, was referred to the bariatric program at UCSF, and in October 2023, she finally got a gastric sleeve. She got down to about 200 pounds from the surgery, then started a different weight-loss drug and lost another 20 pounds. Though she's still obese for her height, Hinz said she's not interested in losing much more weight. 'I'm 180 and completely happy,' Hinz said. 'My journey has been absolutely amazing.' She noted that even with all of the tools at her disposal, losing the weight was never easy. And she has friends for whom even the newest therapies aren't solving all of their weight issues. But for Hinz, the weight-loss drugs finally unlocked a path that had never felt accessible to her. 'Being big my whole life, I missed out on a lot of stuff,' she said. Walking up and down stairs had become difficult, or spending a day on her feet at an amusement park. 'Now I can run up and down the stairs, I can walk around the amusement park the whole day. I went on my first hike a year and a half ago. It's like, let's go, let's do this.' Azagury said he's most thrilled for the patients — and their doctors — who have the most weight to lose, and especially those for whom a combination of medical and surgical therapies could be life-saving. 'The worst thing for a bariatric surgeon is when you get a patient in your clinic and it's too late — their condition is so bad that surgery is unsafe,' Azagury said. 'The conversation is, 'You have a condition I can treat, but I can't treat you.' It's the worst conversation. And I never have to have it anymore. Now I can tell them: 'I can't do surgery, but I have a good alternative for you.''
